| 001739 (2003) |
G. A. Marsh [Australie] ; J. M. Watson [Australie] ; W. E. White [Australie] ; G. A. Tannock [Australie] | An evaluation of the genetic stability and pathogenicity of the Russian cold-adapted influenza A donor strains A/Leningrad/134/17/57 and A/Leningrad/134/47/57 in ferrets |
| 000967 (2013) |
Takayuki Komatsu [Japon] ; Nobuo Kido [Japon] ; Tsuyoshi Sugiyama [Japon] ; Takashi Yokochi [Japon] | Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection |
| 000D62 (2011) |
Larisa Rudenko [Russie, Australie] ; Han Van Den Bosch [Pays-Bas] ; Irina Kiseleva [Russie, Australie] ; Alexander Mironov [Russie] ; Anatoly Naikhin [Russie] ; Natalie Larionova [Russie] ; Dimitry Bushmenkov [Russie] | Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries |
| 000F89 (2010) |
Katrina Sleeman [États-Unis] ; Vasiliy P. Mishin [États-Unis] ; Varough M. Deyde [États-Unis] ; Yousuke Furuta [Japon] ; Alexander I. Klimov [États-Unis] ; Larisa V. Gubareva [États-Unis] | In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses |
| 001569 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001735 (2003) |
Ioannis Stylianakis [Grèce] ; Antonios Kolocouris [Grèce] ; Nicolas Kolocouris [Grèce] ; George Fytas [Grèce] ; George B. Foscolos [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Spiro[pyrrolidine-2,2'-adamantanes]: Synthesis, anti-influenza virus activity and conformational properties |
| 001737 (2003) |
H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis] | Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate |
| 001738 (2003) |
Grigoris Zoidis [Grèce] ; Nicolas Kolocouris [Grèce] ; George B. Foscolos [Grèce] ; Antonios Kolocouris [Grèce] ; George Fytas [Grèce] ; P. Karayannis [Grèce] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Are the 2-isomers of the drug rimantadine active anti-influenza A agents? |
| 001793 (2002) |
I. V. Kiseleva ; A. I. Klimov | En Russe |
| 001984 (1999) |
Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique] | Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling |
| 001B20 (1998) |
S. Bantia [États-Unis] ; A. A. Ghate [États-Unis] ; S. L. Ananth [États-Unis] ; Y. Sudhakar Babu [États-Unis] ; G. M. Air [États-Unis] ; G. M. Walsh [États-Unis] | Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140 |
| 001B55 (1997) |
Brian R. Murphy [États-Unis] ; Eun Ju Park [États-Unis] ; Paul Gottlieb [États-Unis] ; Kanta Subbarao [États-Unis] | An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters |
| 001C09 (1996) |
Nicolas Kolocouris [Belgique] ; Antonios Kolocouris [Belgique] ; George B. Foscolos [Belgique] ; George Fytas [Belgique] ; Johan Neyts [Belgique] ; Elisabeth Padalko [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Graciela Andrei [Belgique] ; Erik De Clercq [Belgique] | Synthesis and Antiviral Activity Evaluation of Some New Aminoadamantane Derivatives. 2 |
| 001E68 (1993) |
Louis F. Fries [États-Unis] ; Susan B. Dillon [États-Unis] ; James E. K. Hildreth [États-Unis] ; Ruth A. Karron [États-Unis] ; Ann W. Funkhouser [États-Unis] ; Carl J. Friedman [États-Unis] ; Christopher S. Jones [États-Unis] ; Vasantha G. Culleton [États-Unis] ; Mary Lou Clements [États-Unis] | Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge |
| 001F37 (1992) |
Alexander I. Klimov [Russie] ; Nancy J. Cox [États-Unis] ; Wagner V. Yotov [Russie] ; Elisabet Rocha [États-Unis] ; Galina I. Alexandrova [Russie] ; Alan P. Kendal [États-Unis] | Sequence changes in the live attenuated, cold-adapted variants of influenza A/Leningrad/134/57 (H2N2) virus |
| 002063 (1991) |
B. Panzing [Allemagne] ; K. B. Lisovskaya ; B. Herrman ; A. Klimov ; L. Döhner | Further studies on cold adapted variants of human influenza virus A/Krasnodar/101/59 (H2N2) with special reference to genetic stability of attenuation markers |
| 002250 (1988) |
Nancy J. Cox [États-Unis] ; Fumio Kitame [Japon] ; Alan P. Kendal [États-Unis] ; Hunein F. Maassab [États-Unis] ; Clayton Naeve [États-Unis] | Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2) |
| 002271 (1988) |
M. H. Snyder ; R. F. Betts ; D. Deborde ; E. L. Tierney ; M. L. Clements ; D. Herrington ; S. D. Sears ; R. Dolin ; H. F. Maassab ; B. R. Murphy | Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines |
| 000D64 (2011) |
Kortney M. Gustin [Géorgie] ; Taronna R. Maines [Géorgie] ; Jessica A. Belser [Géorgie] ; Neal Van Hoeven [Géorgie] ; XUIHUA LU [Géorgie] ; LIBO DONG [Géorgie] ; Irina Isakova-Sivak [Géorgie, Russie] ; Li-Mei Chen [Géorgie] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Nancy J. Cox [Géorgie] ; Terrence M. Tumpey [Géorgie] ; Alexander I. Klimov [Géorgie] ; Larisa Rudenko [Russie] ; Ruben O. Donis [Géorgie] ; Jacqueline M. Katz [Géorgie] | Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets |
| 000F88 (2010) |
J. Theo [Pays-Bas] ; M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 000F90 (2010) |
ZHONGYING CHEN [États-Unis] ; WEIJIA WANG [États-Unis] ; HELEN ZHOU [États-Unis] ; Amorsolo L. Jr Suguitan [États-Unis] ; Cindy Shambaugh [États-Unis] ; Lomi Kim [États-Unis] ; Jackie Zhao [États-Unis] ; George Kemble [États-Unis] ; HONG JIN [États-Unis] | Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs |
| 000F92 (2010) |
Alicia Solorzano [États-Unis] ; JIANQIANG YE [États-Unis] ; Daniel R. Perez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu |
| 000F93 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; BIN LU [États-Unis] ; David Swayne [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and Monkeys |
| 001203 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron [États-Unis] ; Karen A. Callahan [États-Unis] ; Catherine J. Luke [États-Unis] ; Susan C. Dilorenzo [États-Unis] ; Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; HONG JIN [États-Unis] ; Kathy L. Coelingh [États-Unis] ; Brian R. Murphy [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults |
| 001348 (2008) |
Antonios Kolocouris [Grèce] ; Philip Spearpoint [Royaume-Uni] ; Stephen R. Martin [Royaume-Uni] ; Alan J. Hay [Royaume-Uni] ; Marta Lopez-Querol [Espagne] ; Francesc X. Sureda [Espagne] ; Elizaveta Padalko [Belgique] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues |
| 001454 (2007) |
JAE MIN SONG [Corée du Sud] ; KI DUK PARK [Corée du Sud] ; KWANG HEE LEE [Corée du Sud] ; YOUNG HO BYUN [Corée du Sud] ; JU HEE PARK [Corée du Sud] ; SUNG HAN KIM [Corée du Sud] ; JAE HONG KIM [Corée du Sud] ; BAIK LIN SEONG [Corée du Sud] | Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives |
| 001566 (2006) |
Grigoris Zoidis [Grèce] ; Christos Fytas [Grèce] ; Loannis Papanastasiou [Grèce] ; George B. Foscolos [Grèce] ; George Fytas [Grèce] ; Elizaveta Padalko [Belgique] ; Erik De Clercq [Belgique] ; Lieve Naesens [Belgique] ; Johan Neyts [Belgique] ; Nicolas Kolocouris [Grèce] | Heterocyclic rimantadine analogues with antiviral activity |
| 001647 (2005) |
Mark D. Wareing [Australie] ; Leonard C. Harrison [Australie] ; Gregory A. Tannock [Australie] | Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains |
| 001794 (2002) |
E. P. Grigoryeva ; Ya. A. Desheva ; S. A. Donina ; A. N. Naikhin ; A. R. Rekstin ; I. B. Barantseva ; E. A. Zavitkova ; T. M. Moskvichyova ; V. G. Zhavoronkov ; L. G. Rudenko | En Russe |
| 001822 (2001) |
George Stamatiou [Grèce] ; Antonios Kolocouris [Grèce] ; Nicolas Kolocouris [Grèce] ; George Fytas [Grèce] ; George B. Foscolos [Grèce] ; Johan Neyts [Belgique] ; Erik De Clercq [Belgique] | Novel 3-(2-Adamantyl)pyrrolidines with potent activity against influenza A virus—identification of aminoadamantane derivatives bearing two pharmacophoric amine groups |
| 001997 (1999) |
Venkatram R. Atigadda [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Franco Duarte [États-Unis] ; Yarlagadda S. Babu [États-Unis] ; Shanta Bantia [États-Unis] ; Pooran Chand [États-Unis] ; Naiming Chu [États-Unis] ; John A. Montgomery [États-Unis] ; David A. Walsh [États-Unis] ; Elise Sudbeck [États-Unis] ; James Finley [États-Unis] ; Gillian M. Air [États-Unis] ; Ming Luo [États-Unis] ; Graeme W. Laver [Australie] | Hydrophobic benzoic acids as inhibitors of influenza neuraminidase |
| 001A44 (1998) |
Daisei Miyamoto [Japon] ; Yuki Kusagaya [Japon] ; Naoko Endo [Japon] ; Ayako Sometani [Japon] ; Seiji Takeo [Japon] ; Takashi Suzuki [Japon] ; Yaeno Arima [Japon] ; Katsuyuki Nakajima [États-Unis] ; Yasuo Suzuki [Japon] | Thujaplicin–copper chelates inhibit replication of human influenza viruses |
| 001A96 (1998) |
A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni] | Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2) |
| 001B04 (1998) |
C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis] | How to overcome resistance of influenza A viruses against adamantane derivatives |
| 001C90 (1996) |
K. G. Nicholson [Royaume-Uni] | Use of antivirals in influenza in the elderly : Prophylaxis and therapy |
| 001D33 (1995) |
G. A. Tannock [Australie] ; J. R. Romanova [Russie] ; J. A. Paul [Australie] | The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene |
| 001E15 (1994) |
M. A. Ball [États-Unis] ; T. Utsunomiya [États-Unis] ; K. Ikemoto [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | The antiviral effect of Keishi-ni-eppi-ichi-to, a tranditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice |
| 001F17 (1993) |
T. E. Medvedeva [Russie] ; V. K. Kudryavtseva ; G. N. Nevedomskaya ; I. V. Zhikhareva ; M. I. Gushchina ; F. N. Zolotarev ; G. M. Vodeiko ; K. V. Lisovskaya ; V. V. Iotov ; M. I. Khaider ; V. V. Yarosh ; A. I. Klimov ; G. I. Aleksandrova | Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/leningrad/134/47/57 (H2N2), a donor for attenuation of living influenza vaccines |
| 001F18 (1993) |
J. R. Sch Fer [États-Unis] ; Yoshihiro Kawaoka [États-Unis] ; W. J. Bean [États-Unis] ; J. Süss ; D. Senne ; R. G. Webster [États-Unis] | Origin of the pandemic 1957 H2 influenza A viruses and the persistence of its possible progenitors in the avian reservoir |
| 002191 (1989) |
M. H. Pritchard ; J. Munro | Successful treatment of juvenile chronic arthritis with a specific antiviral agent |
| 002192 (1989) |
Yoshihiro Kawaoka [États-Unis] ; S. Krauss ; R. G. Webster | Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics |
| 002270 (1988) |
R. B. Belshe ; M. Hall Smith ; C. B. Hall ; R. Betts ; A. J. Hay | Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection |
| 002272 (1988) |
A. Z. Plyusnin ; S. A. Rozhkova ; O. V. Nolandt ; E. A. Bryantseva ; F. S. Poskov | |
| 002334 (1987) |
E. E. Rozina ; O. E. Khudaverdyan ; Yu. Z. Ghendon | Clinical and morphologic studies on the guinea pig eye infected with human influenza virus strains of different virulence |
| 002420 (1985) |
D. B. Golubev [Russie] ; G. I. Karpukhin [Russie] ; S. S. Galitarov [Russie] ; G. M. Denisov [Russie] | Type A influenza (H2N2) viruses isolated in Leningrad in 1980 |
| 002627 (1983) |
F. I. Polezhaev ; G. N. Budilovskij ; L. M. Garmashova ; Yu. R. Romejko-Gurko ; A. Yu. Egorov ; N. V. Topuriya ; T. A. Koval ; G. I. Aleksandrova | |
| 000253 (2017) |
Noemie Courtin [France] ; Aurelien Fotso Fotso [France] ; Pierre Fautrad [France] ; Floriane Mas [France] ; Marie-Christine Alessi [France] ; Beatrice Riteau [France] | Antiviral activity of Formyl Peptide Receptor 2 antagonists against influenza viruses |
| 000389 (2016) |
Paul Loubet [France] ; Nezha Samih-Lenzi [France] ; Florence Galtier [France] ; Philippe Vanhems [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Stéphane Jouneau [France] ; Déborah Postil [France] ; Sylvie Rogez [France] ; Martine Valette [France] ; Corinne Merle [France] ; Corinne Régis [France] ; Yolande Costa [France] ; Zineb Lesieur [France] ; Pierre Tattevin [France] ; Bruno Lina [France] ; Fabrice Carrat [France] ; Odile Launay [France] | Factors associated with poor outcomes among adults hospitalised for influenza in France: A three-year prospective multicenter study |
| 000B01 (2012) |
William G. Dundon [Italie] | Variability among the neuraminidase, non-structural 1 and PB1-F2 proteins in the influenza A virus genome |
| 000B45 (2012) |
JIANZHONG SHI [République populaire de Chine] ; ZHIYUAN WEN [République populaire de Chine] ; JING GUO [République populaire de Chine] ; YING ZHANG [République populaire de Chine] ; GUOHUA DENG [République populaire de Chine] ; YUELONG SHU [République populaire de Chine] ; DAYAN WANG [République populaire de Chine] ; YONGPING JIANG [République populaire de Chine] ; Yoshihiro Kawaoka [Japon] ; ZHIGAO BU [République populaire de Chine] ; HUALAN CHEN [République populaire de Chine] | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice |
| 000B48 (2012) |
CHAO QIU [République populaire de Chine] ; YANG HUANG [République populaire de Chine] ; QIAN WANG [République populaire de Chine] ; DI TIAN [République populaire de Chine] ; WANJU ZHANG [République populaire de Chine] ; YUNWEN HU [République populaire de Chine] ; ZHENGHONG YUAN [République populaire de Chine] ; XIAOYAN ZHANG [République populaire de Chine] ; JIANQING XU [République populaire de Chine] | Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine |
| 000D58 (2011) |
Geneviève Girard [Pays-Bas] ; Alexander P. Gultyaev [Pays-Bas] ; René C. L. Olsthoorn [Pays-Bas] | Upstream start codon in segment 4 of North American H2 avian influenza A viruses |
| 000F95 (2009-12-11) |
Corinne Bergeron [France] | Genetic composition of H3N2 vaccine seeds and vector virus construction : a story of packaging in type A Influenza viruses |
| 001005 (2009-07) |
Yongjin Wang [République populaire de Chine] ; Licheng Zhou [République populaire de Chine] ; Huiling Shi [République populaire de Chine] ; Hongwei Xu [République populaire de Chine] ; Hong Yao [République populaire de Chine] ; Xu Guang Xi [France] ; Tetsuya Toyoda [République populaire de Chine] ; Xiaoming Wang [République populaire de Chine] ; Tianhou Wang [République populaire de Chine] | Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells |
| 001155 (2009) |
Poramate Pitak-Arnnop [Allemagne, France] ; Stefan Schubert [Allemagne] ; Kittipong Dhanuthai [Thaïlande] ; Kraison Sappayatosok [Thaïlande] ; Ute Bauer [Allemagne] ; Pichit Ngamwannagul [Thaïlande] ; Uwe Gerd Liebert [Allemagne] ; Alexander Hemprich [Allemagne] | Swine-origin H1N1 influenza A virus and dental practice: a critical review |
| 001173 (2009) |
Kyungdong Bae [Corée du Sud] ; Junyoul Choi [Corée du Sud] ; Yangsuk Jang [Corée du Sud] ; Sangjeom Ahn [Corée du Sud] ; Byungki Hur [Corée du Sud] | Innovative vaccine production technologies: The evolution and value of vaccine production technologies |
| 001176 (2009) |
Seyyed Mahmoud Ebrahimi [Iran] ; Majid Tebianian [Iran] | Heterologous expression, purification and characterization of the influenza A virus M2e gene fused to Mycobacterium tuberculosis HSP70359–610 in prokaryotic system as a fusion protein |
| 001192 (2009) |
Sebastian U. Schnitzler [Allemagne] ; Paul Schnitzler [Allemagne] | An update on swine-origin influenza virus A/H1N1: a review |
| 001202 (2009) |
Irina A. Leneva [Royaume-Uni, Russie] ; Rupert J. Russell [Royaume-Uni] ; Yury S. Boriskin [Russie] ; Alan J. Hay [Royaume-Uni] | Characteristics of arbidol-resistant mutants of influenza virus : Implications for the mechanism of anti-influenza action of arbidol |
| 001345 (2008) |
Nigel J. Dimmock [Royaume-Uni] ; Edward W. Rainsford [Royaume-Uni] ; Paul D. Scott [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni] | Influenza Virus Protecting RNA : an Effective Prophylactic and Therapeutic Antiviral |
| 001346 (2008) |
JOO SUB LEE [Corée du Sud] ; HYUN SOO KIM [Corée du Sud] ; SANG HEUI SEO [Corée du Sud] | Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine |
| 001434 (2007) |
Jayanta Haldar [États-Unis] ; Jianzhu Chen [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Larisa V. Gubareva [États-Unis] ; Alexander M. Klibanov [États-Unis] | Hydrophobic polycationic coatings inactivate wild-type and zanamivir- and/or oseltamivir-resistant human and avian influenza viruses |
| 001453 (2007) |
Hiroshi Nishiura [Allemagne, Japon] ; Gerardo Chowell [États-Unis] | HOUSEHOLD AND COMMUNITY TRANSMISSION OF THE ASIAN INFLUENZA A (H2N2) AND INFLUENZA B VIRUSES IN 1957 AND 1961 |
| 001455 (2007) |
Deepanker Tewari [États-Unis] ; Corey Zellers [États-Unis] ; Helen Acland [États-Unis] ; Janice C. Pedersen [États-Unis] | Automated extraction of avian influenza virus for rapid detection using real-time RT-PCR |
| 001528 (2006) |
H. W. Doerr [Allemagne] ; Domenica Varwig [Allemagne] ; Regina Allwinn [Allemagne] ; J. Cinatl [Allemagne] | Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter |
| 001547 (2006) |
Insung Ahn [Corée du Sud] ; Byeong-Jin Jeong [Corée du Sud] ; Se-Eun Bae [Corée du Sud] ; Jin Jung [Corée du Sud] ; Hyeon S. Son [Corée du Sud] | Genomic Analysis of Influenza A Viruses , including Avian Flu (H5N1) Strains |
| 001565 (2006) |
Nigel J. Dimmock [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni] | In vivo antiviral activity : defective interfering virus protects better against virulent Influenza A virus than avirulent virus |
| 001570 (2006) |
D. J. Alexander [Royaume-Uni] | Avian influenza viruses and human health |
| 001571 (2006) |
Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Avian influenza virus infections in humans |
| 001594 (2005) |
Cécile Viboud ; Rebecca F. Grais ; Bernard A. P. Lafont [États-Unis] ; Mark A. Miller ; Lone Simonsen [États-Unis] | Multinational Impact of the 1968 Hong Kong Influenza Pandemic: Evidence for a Smoldering Pandemic |
| 001645 (2005) |
Colin R. Parrish [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon] | The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses |
| 001759 (2002) |
Jeffrey J. Landers ; Zhengyi Cao ; Inhan Lee ; Lars T. Piehler ; Piotr P. Myc ; Andrzej Myc ; Tarek Hamouda ; Andrzej T. Galecki ; James R. Baker | Prevention of Influenza Pneumonitis by Sialic Acid–Conjugated Dendritic Polymers |
| 001790 (2002) |
W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis |
| 001795 (2002) |
Yu. A. Desheva ; G. V. Danini ; E. P. Grigoryeva ; S. A. Donina ; I. V. Kiseleva ; A. R. Rekstin ; L. A. Ermakova ; V. K. Natsina ; V. M. Nikolaeva ; N. I. Lonskaya ; G. A. Elshina ; V. G. Zhavoronkov ; V. P. Drinevsky ; M. K. Erofeeva ; A. N. Naikhin ; L. G. Rudenko | En Russe |
| 001894 (2001) |
B. Schweiger [États-Unis] | Nationale und globale Influenzasurveillance als Basis der jährlichen Impfstoffempfehlung |
| 001964 (2000) |
B. Schweiger [États-Unis] ; H. Timm [États-Unis] | TaqMan-PCR: Schnelle Typisierung und Subtypisierung von Influenzaviren direkt aus Patientenmaterial |
| 001A38 (1999) |
M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice |
| 001A53 (1998) |
Lone Simonsen [Géorgie (pays)] ; Matthew J. Clarke [Géorgie (pays)] ; Lawrence B. Schonberger [Géorgie (pays)] ; Nancy H. Arden [Géorgie (pays)] ; Nancy J. Cox [Géorgie (pays)] ; Keiji Fukuda [Géorgie (pays), États-Unis] | Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution |
| 001A67 (1998) |
Suryaprakash Sambhara [Suède] ; Samantha Woods [Suède] ; Rita Arpino [Suède] ; Anjna Kurichh [Suède] ; Alan Tamane [Suède] ; Brian Underdown [Suède] ; Michel Klein [Suède] ; Karin Lövgren Bengtsson [Suède] ; Bror Morein [Suède] ; David Burt [Suède] | Heterotypic Protection against Influenza by Immunostimulating Complexes Is Associated with the Induction of Cross-Reactive Cytotoxic T Lymphocytes |
| 001B98 (1997) |
T. Utsunomiya [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus |
| 001C27 (1996) |
Shinichi Sakamoto [Japon] ; Yoichiro Kino [Japon] ; Testuya Oka [Japon] ; M. Louise Herlocher [États-Unis] ; Hunien F. Maassab [États-Unis] | Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion |
| 001E22 (1994) |
B. Schweiger [Allemagne] ; I. Lange [Allemagne] ; R. Heckler [Allemagne] ; H. Willers [Allemagne] ; E. Schreier [Allemagne] | Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay |
| 001E47 (1994) |
M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis] | Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses |
| 001F19 (1993) |
M. L. Herlocher [États-Unis] ; H. F. Maassab ; R. G. Webster [États-Unis] | Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus |
| 001F20 (1993) |
H. Nakao [Japon] ; K. Nakajima [Japon] ; S. Nakajima | Location on the evolutionary trees of the non-structural protein (NS) and neuraminidase (NA) genes of late human influenza A (H3N2) viruses : parental viruses of the NS and NA genes of Hong Kong influenza A (H3N2) viruses |
| 001F21 (1993) |
R. A. Black [États-Unis] ; P. A. Rota [États-Unis] ; N. Gorodkova ; H.-D. Klenk ; A. P. Kendal [États-Unis] | Antibody response to the M2 protein of influenza A virus expressed in insect cells |
| 001F22 (1993) |
Y. Okuno [Japon] ; Y. Isegawa ; F. Sasao ; S. Ueda | A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains |
| 001F88 (1992) |
E. Kanta Subbarao [États-Unis] ; M. Perkins ; J. J. Treanor ; B. R. Murphy | The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect |
| 002128 (1990) |
I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. Couch | Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes |
| 002326 (1987) |
G. A. Tannock [Australie] ; Judith A. Paul [Australie] | Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca |
| 002352 (1986) |
Tadao Sonoguchi [Japon] ; Mitsuo Sakoh [Japon] ; Nobuharu Kunita [Japon] ; Kiyoaki Satsuta [Japon] ; Hideo Noriki [Japon] ; Hideo Fukumi [Japon] | Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in Japan |
| 002406 (1986) |
J. R. Bennink ; J. W. Yewdell ; G. L. Smith ; B. Moss | Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes |
| 002426 (1985) |
Sukla Basak [États-Unis] ; Milan Tomana [États-Unis] ; Richard W. Compans [États-Unis] | Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase |
| 002473 (1985) |
SHU-FANG TIAN ; A. J. Buckler-White ; W. T. London ; L. J. Reck ; R. M. Chanock ; B. R. Murphy | Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract |
| 002496 (1984) |
W. Graeme Laver [République populaire de Chine] ; Robert G. Webster [République populaire de Chine] ; C. M. Chu [République populaire de Chine] | Summary of a Meeting on the Origin of Pandemic Influenza Viruses |
| 002523 (1984) |
A. Yamada [États-Unis] ; L. E. Brown [États-Unis] ; R. G. Webster [États-Unis] | Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: Influence of receptor specificity |
| 002530 (1984) |
R. G. Webster [États-Unis] ; L. E. Brown [États-Unis] ; W. G. Laver [États-Unis] | Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies |
| 002541 (1984) |
K. Nerome [Japon] ; Y. Yoshioka [Japon] ; C. A. Torres [Japon] ; A. Oya [Japon] ; P. Bachmann [Allemagne] ; K. Ottis [Allemagne] ; R. G. Webster [États-Unis] | Persistence of Q strain of H2N2 influenza virus in avian species: Antigenic, biological and genetic analysis of avian and human H2N2 viruses |
| 002552 (1984) |
R. B. Belshe ; L. P. Van Voris ; J. Bartram ; F. K. Crookshanks | Live attenuated influenza A virus vaccines in children: results of a field trial |
| 002553 (1984) |
D. A. Buonagurio ; M. Krystal ; P. Palese ; D. C. Deborde ; H. F. Maassab | Analysis of an influenza A virus mutant with a deletion in the NS segment |
